What is the appropriate clonidine dosing regimen for patients undergoing methadone withdrawal, including initial dose, titration, maximum dose, duration, and tapering schedule?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Clonidine Dosing for Methadone Withdrawal

For methadone withdrawal, start clonidine at 0.1-0.2 mg orally every 6 hours, with peak dosing typically reaching 16 mcg/kg/day (approximately 1.0-1.2 mg/day for a 70 kg adult) by day 2, then taper over 10-11 days. 1, 2

Initial Dosing

  • Start with 0.1-0.2 mg orally every 6 hours 1
  • Administer when withdrawal symptoms are present but patient is not sedated
  • Monitor blood pressure before each dose, as hypotension is the primary limiting adverse effect

Titration and Peak Dosing

The evidence from controlled inpatient studies demonstrates a specific pattern:

  • Peak dose occurs on day 2 of withdrawal, averaging 16 mcg/kg/day (approximately 1.0-1.2 mg/day for a 70 kg adult) 2
  • Doses can be increased based on withdrawal symptom severity, but monitor for hypotension
  • Most patients require 10-11 days of clonidine administration for complete methadone withdrawal 2

Maximum Dosing Considerations

While the FDA label indicates doses up to 2.4 mg/day are the maximum effective dose for hypertension 3, research in methadone withdrawal used peak mean doses around 1.0-1.2 mg/day with good efficacy 2. When combined with naltrexone for rapid withdrawal, peak doses reached 2.9 mg/day 4, but this is a specialized protocol.

Duration and Tapering

  • Total treatment duration: 10-11 days for standard methadone withdrawal 2
  • After peak dosing on day 2, gradually reduce dose as withdrawal symptoms improve
  • Critical warning: Do not stop abruptly if used for more than 9 weeks, as this can cause rebound hypertension, tachycardia, and hypertonia 1

Important Clinical Considerations

Symptoms Resistant to Clonidine

The following symptoms are most resistant to clonidine treatment and may require adjunctive therapy 2, 4:

  • Anxiety
  • Restlessness
  • Insomnia
  • Muscular aching

Consider adding: Doxepin 100 mg and/or nitrazepam 10 mg (only until day 4) for insomnia 5, or other appropriate anxiolytics/sleep aids.

Monitoring Requirements

  • Blood pressure monitoring is essential before each dose
  • Clonidine significantly reduces standing blood pressure 2
  • Hypotensive adverse effects occur more frequently with alpha-2 agonists compared to methadone taper (RR 1.92) 6, 7
  • Watch for: sedation, dizziness, dry mouth, headache, fatigue 1

Contraindications and Cautions

  • Use caution in cardiovascular disease, bradycardia, or heart block 1
  • Pregnancy class C 1
  • Renal impairment may require lower initial doses 3

Efficacy Compared to Alternatives

Clonidine is significantly more effective than placebo (RR 0.32 for severe withdrawal, completion rate RR 1.95) 6, 7, but the evidence shows:

  • Peak withdrawal may be slightly greater with clonidine than methadone taper, though not statistically significant 6, 7
  • Withdrawal symptoms occur and resolve earlier with clonidine than methadone taper 6, 7
  • Methadone taper has fewer adverse effects than clonidine 6, 7
  • No significant difference in treatment completion rates between clonidine and methadone taper (RR 0.85) 6, 7

Common Pitfall

The most common error is inadequate dosing on day 2 when withdrawal symptoms peak. Be prepared to increase to the full 16 mcg/kg/day if symptoms are not controlled, provided blood pressure tolerates it.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.